|
{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID
|
DB07999 |
|
|
Bis(5-Amidino-Benzimidazolyl)Methane Zinc
|
DB04008 |
|
|
Dimethyl Propionate Ester Heme
|
DB04009 |
|
|
MN-305
|
DB05339 |
[MN-305 is a novel, potent and highly selective serotonin 5-HT1A receptor agonist under development by MediciNova for the treatment of anxiety disorders beginning with Generalized Anxiety Disorder (GAD).] |
|
Arverapamil
|
DB06669 |
|
|
[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone
|
DB04006 |
|
|
(RP,SP)-O-(2R)-(1-PHENOXYBUT-2-YL)-METHYLPHOSPHONIC ACID CHLORIDE
|
DB07990 |
|
|
Bromo-WR99210
|
DB04007 |
|
|
SOT-107
|
DB05337 |
[SOT-107 is a drug that is a combination of a protein called transferrin and a poison called diphtheria toxin. This drug treat for a type of brain cancer called a high grade glioma brain tumour. About half of all brain tumours are gliomas. ] |
|
N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE
|
DB07991 |
|
|
Obiltoxaximab
|
DB05336 |
[Obiltoxaximab, an affinity-enhanced monoclonal antibody (Mab), is used for prevention and treatment of infection and death caused by anthrax toxin. Obiltoxaximab is a chimeric IgG1 kappa monoclonal antibody (mAb) that binds the PA component of B. anthracis toxin. It has an approximate molecular weight of 148 kDa.] |
|
2,6-Diamino-8-(2-Dimethylaminoethylsulfanylmethyl)-3h-Quinazolin-4-One
|
DB04004 |
|
|
3-SULFOOXY-1H-INDOLE
|
DB07992 |
|
|
Uridine 5'-triphosphate
|
DB04005 |
[Uridine 5'-(tetrahydrogen triphosphate). A uracil nucleotide containing three phosphate groups esterified to the sugar moiety.] |
|
Lixivaptan
|
DB06666 |
|
|
N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE
|
DB07993 |
|
|
4-Sulfonamide-[4-(Thiomethylaminobutane)]Benzamide
|
DB04002 |
|
|
{4-[(2S)-2-Acetamido-3-({(1S)-1-[3-carbamoyl-4-(cyclohexylmethoxy)phenyl]ethyl}amino)-3-oxopropyl]-2-phosphonophenoxy}acetic acid
|
DB04003 |
|
|
TC-5231
|
DB05333 |
[TC-5231 is a small molecule that has been under investigation as an oral treatment for ADHD (Attention Deficit/Hyperactivity Disorder). TC-5231 is mecamylamine hydrochloride, the active ingredient in FDA-approved product, Inversine, but in a lower dose than Inversine. ] |
|
N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE
|
DB07994 |
|
